Cullinan Therapeutics, Inc.Cullinan Therapeutics, Inc.Cullinan Therapeutics, Inc.

Cullinan Therapeutics, Inc.

No trades
See on Supercharts

Price target

28.000.00 0.00%
The 6 analysts offering 1 year price forecasts for CGEM have a max estimate of — and a min estimate of —.

Analyst rating

Based on 8 analysts giving stock ratings to CGEM in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

CGEM EPS for the last quarter is −0.54 USD despite the estimation of −0.96 USD. In the next quarter EPS is expected to reach −0.97 USD. Track more of Cullinan Therapeutics, Inc. financials and stay on top of what is up with the company.
According to analysts, CGEM price target is 28.00 USD with a max estimate of 36.00 USD and a min estimate of 19.00 USD. Check if this forecast comes true in a year, meanwhile keep track of the current situation with CGEM news and stock market news.
We've gathered opinions of 8 analysts rating CGEM stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.